Aalto computer scientists in VLDB 2024
VLDB is a premier annual international forum for data management, scalable data science and database researchers, vendors, practitioners, application developers, and users. VLDB covers issues in data management, database architectures, graph data management, data privacy and security, data mining, machine learning, AI and database systems research.
The conference will take place in Guangzhou, China, on August 26th - August 30th, 2024.
Accepted papers
In alphabetical order. Click the title to see the authors and the abstract.
Authors
Alessandro Fogli, Bo Zhao (Aalto University), Peter Pietzuch, Maximilian Bandle, Jana Giceva
Abstract
Chiplet-based CPUs, which combine multiple independent dies on a single package, allow hardware to scale to higher CPU core counts at the cost of more memory heterogeneity and performance variability. This introduces challenges when existing query engines are deployed on chiplet-based CPUs, as current designs make assumptions about uniform memory access, cache locality and consistent core performance, e.g., leading to ineffective CPU utilization. In this paper, we analyse the performance impact when query engines ignore chiplet-specific properties. We demonstrate that a naïve deployment can result in a significant degradation of query processing efficiency, exhibiting non-linear scaling even within a single CPU socket domain. Based on comprehensive experiments, we explore approaches to deploy query engines on chiplet-based CPUs with improved performance: we show that distributing processing tasks according to a chiplet-aware strategy achieves higher resource utilization and scalability, yielding an up to 7 times speedup compared to hardware-oblivious approaches.
Read more news
ACRIS service restored
The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Science must have a voice in society – but how?
Trust in science has fallen in Finland by almost ten percentage points in two years
Meet our startup: Proteins.1 aims for a breakthrough in early disease detection
Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.